RBM47 has been shown to inhibit the progression of several malignancies, including thyroid carcinoma, nasopharyngeal carcinoma, lung cancer and colorectal cancer, whereas its role in PCa has not been characterized.30, 31, 32, 33. This evidence concerns the gene RBM47 and lung cancer.